20:11 IST
BSE
Results Update
RPG Life Sciences Results Update
RPG Life Sciences reported Q1 FY27 Revenue of ₹195.7 Crore, a 15.8% increase, with EBITDA growing 17.9% to ₹48.0 Crore.
RPG Life Sciences Ltd
- Share price
- ₹2,892.80
- Market cap
- ₹4,784 Cr
- Revenue (annual)
- ₹707.5 Cr
- Net profit (annual)
- ₹115.2 Cr
- P/E (TTM)
- 40.0×Sector 47.3×
- Promoter holding
- 72.95%+0.00% QoQ
- FII holding
- 0.95%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Merger & Restructuring 10Financial Results 5Other Announcement 4Earnings Call 4Management Change 3Acquisition 3Results Update 2Price Movement Clarification 2Annual General Meeting 2Product Launch 1Dividend 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
20:44 IST
BSE
Results Update
RPG Life Sciences Results Update
RPG Life Sciences reported a 23.6% Y-o-Y revenue increase to ₹176.9 Crore for Q4 FY26, with an EBITDA margin of 25.6%. Full-year FY26 revenue grew 8.3% to ₹707.5 Crore. The Board recommended a 300% dividend (₹24 per share). Growth was driven by robust performance in Domestic Formulations and a strong recovery in the API division.